If you manage your diabetes with one of the intermediate acting insulins, its variability from day to day might alarm you. Maybe you aren’t mixing it well enough.
This type of insulin takes one to three hours to start working and lasts for 12 to 16 hours. Its generic name is NPH; Novo Nordisk sells it as Novolin N and Lilly as Humulin N. NPH is also available premixed with short acting insulin.
But NPH insulin is itself a mixture, and that’s the problem. Its cloudy part is rich in insulin crystals while its clear part isn’t. Before you inject it, you have to mix these parts.
An insulin pen is a convenient way to inject NPH, and a typical recommendation is to “roll and gently shake 10 times” every time you use it. A study just published online ahead of print in the professional journal Diabetes Care shows that this isn’t good enough.
Only the abstract of his study by eight researchers at Italy’s Perugia University School of Medicine is online. The lead author, Paola Lucidi, M.D., Ph.D., sent me a copy of the full-text.
Using an Insulin Pen
They enrolled a small group of 11 people with type 1 diabetes in a randomized, open-label, crossover design study. For the study they used an insulin pen.
The study looked at the different effect of adequately mixing the insulin the pen compared with just holding it (1) horizontally, (2) vertically with the tip up, or (3) vertically with the tip down without trying to mix it. The differences were “profound,” the researchers wrote. They “may importantly contribute to day-to-day glycemic variability of type 1 diabetes.”
Mix Gently and Long
These are “extreme situations” compared with “the more common condition where patients inject NPH insulin after only partial, incomplete re-suspension,” they wrote. They found that you need to gently tip the pen 20 times during one and one-half minutes before injecting, admitting that this is “quite long for preparation of an insulin injection.” But it is “a key step that some patients might totally or partially skip.”
NPH Properly Mixed Is an Alternative to Long Acting Insulins
This study examined NPH injections only with pens and not with vials, although the study authors “anticipate similar findings.” And it doesn’t apply to long acting insulins like Lantus or Levemir, which more of us use.
But those long acting insulins are expensive, and some of the people who have diabetes can’t afford them. Many people stay with NPH or have switched back to it when the cost of Lantus or Levemir became beyond their means.
The message for anyone who is uses NPH is clear: shake it gently and for a long enough time.
See more of my articles about how to manage diabetes:
David Mendosa was a journalist who learned in 1994 that he had type 2 diabetes, which he wrote about exclusively. He died in May 2017 after a short illness unrelated to diabetes. He wrote thousands of diabetes articles, two books about it, created one of the first diabetes websites, and published a monthly newsletter, “Diabetes Update.” His very low-carbohydrate diet, A1C level of 5.3, and BMI of 19.8 kept his diabetes in remission without any drugs until his death.